COST-EFFECTIVENESS OF CHEMOPREVENTION WITH DUTASTERIDE BASED ON RESULTS FROM THE REDUCE CLINICAL TRIAL

被引：0
|
作者：
Earnshaw, S. R. [1 ]
McDade, C. L. [1 ]
Black, L. [2 ]
Kattan, M. W. [3 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74327-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial
    Kattan M.W.
    Earnshaw S.R.
    McDade C.L.
    Black L.K.
    Andriole G.L.
    [J]. Applied Health Economics and Health Policy, 2011, 9 (5) : 305 - 315
  • [2] COST-EFFECTIVENESS OF DUTASTERIDE AS A CHEMOPREVENTION IN PROSTATE CANCER: REDUCE WITHIN-TRIAL ANALYSIS
    Earnshaw, S. R.
    Chirila, C.
    McDade, C.
    Black, L.
    Andriole, G. L.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A11 - A11
  • [3] Chemoprevention using dutasteride: the REDUCE trial
    Gomella, LG
    [J]. CURRENT OPINION IN UROLOGY, 2005, 15 (01) : 29 - 32
  • [4] COST-EFFECTIVENESS OF COMBINATION THERAPY WITH DUTASTERIDE/TAMSULOSIN: AN ANALYSIS BASED ON CONDUCT TRIAL
    Vallejo-Aparicio, L. A.
    Minana Lopez, B.
    Brenes, F. J.
    Molero, J. M.
    Fernandez-Pro, A.
    Huerta, A.
    Cozar, J. M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A518 - A518
  • [5] THE COST-EFFECTIVENESS OF AURANOFIN - RESULTS OF A RANDOMIZED CLINICAL-TRIAL
    THOMPSON, MS
    READ, JL
    HUTCHINGS, HC
    PATERSON, M
    HARRIS, ED
    [J]. JOURNAL OF RHEUMATOLOGY, 1988, 15 (01) : 35 - 42
  • [6] Cost-effectiveness considerations in chemoprevention of cancer
    Habbema, JDF
    vanderHeide, A
    vandenBosch, JMH
    Bonneux, L
    [J]. CHEMOPREVENTION IN CANCER CONTROL, 1996, (136): : 131 - 138
  • [7] Bayesian cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    Montmartin, J
    [J]. STATISTICS IN MEDICINE, 2001, 20 (05) : 733 - 753
  • [8] A framework for cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    [J]. HEALTH ECONOMICS, 2001, 10 (04) : 303 - 315
  • [9] REHABILITATION IN RESURFACING HIP ARTHROPLASTY PATIENTS: PRELIMINARY COST-EFFECTIVENESS RESULTS FROM A CLINICAL TRIAL
    Fusco, F.
    Campbell, H.
    Newman, M.
    Barker, K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A381 - A382
  • [10] Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial
    Kuhlmann, Paige K.
    Fischer, Sean C.
    Howard, Lauren E.
    Moreira, Daniel M.
    Andriole, Gerald L.
    Hopp, Martin L.
    Roehrborn, Claus G.
    Bliwise, Donald L.
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (06): : 1733 - 1739
12345